Jazz Pharmaceuticals PLC (JAZZ)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 1,857,970 | 1,419,170 | 1,021,920 | 2,197,740 | 2,007,670 |
| Revenue | US$ in thousands | 3,809,840 | 3,569,430 | 2,999,690 | 2,284,420 | 2,097,480 |
| Gross profit margin | 48.77% | 39.76% | 34.07% | 96.21% | 95.72% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $1,857,970K ÷ $3,809,840K
= 48.77%
The gross profit margin of Jazz Pharmaceuticals plc has shown fluctuations over the past five years. In 2023, the gross profit margin increased to 88.64% from 85.23% in 2022. This improvement indicates the company's ability to efficiently generate profits from its core operations. However, it is worth noting that the gross profit margin was higher in 2020 and 2019 at 93.70% and 94.08%, respectively.
Overall, Jazz Pharmaceuticals plc has maintained a relatively high gross profit margin compared to the industry average, which suggests strong pricing power and effective cost management strategies. The recent increase in the gross profit margin in 2023 reflects a positive trend in the company's profitability, but it would be beneficial to further assess the drivers behind these fluctuations to ensure sustained financial performance.
Peer comparison
Dec 31, 2023